News and Announcements
Can Investors Be Qualified Directors? Who Takes The Seat At The Board?
- Published December 14, 2022 4:10AM UTC
- Publisher Osama Hassan
- Categories Capital Raising Tips
Lead investors ask for board seats; qualify them first.
Boards play a crucial role in a startup’s success or failure, and with a few precious seats to give out, you want to assure yourself that you’re not just getting a good investor but also a good and productive board member.
Just because someone invests does not mean that:
(a) they know how to be a good director, and
(b) they can help add value to improve the probability of a startup’s success.
Just like investors owe it to themselves to do due diligence on the company they’re about to invest in, founders should also do due diligence on the investor by talking to companies where they serve or have served in the past.
You want both the best investors and the best directors.
Click here to view the original Linkedin post.
Looking for a platform to raise capital? Click here to discover how Wholesale Investor can help you.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Capital Raising Tips
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
